Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Glycoproteins associated with nuclear matrices from hamster, chicken and frog liver cells: detection and characterization

100%
Krześlak A., Lipińska A., University of Łódź D. o. C.
Acta Universitatis Lodziensis. Folia Biochimica et Biophysica
|
1999
|
vol. 14
PL
Badano glikoproteiny matriks jądrowej wątroby chomika, kury i żaby. Nasze wyniki wykazują podobieństwo wykresów glikoprotein rozpoznawanych przez konkanawalinę A (ConA) matriks jądrowej wątroby badanych gatunków zwierząt w przeciwieństwie do wykresów glikoprotein otrzymanych po zastosowaniu lektyny z Galanthus nivalis (GNA). Może to odzwierciedlać różnice w strukturze łańcucha oligosacharydowego pewnych glikoprotein matriks jądrowej wątroby chomika, kury i żaby.
2
Publication available in full text mode
Content available

The basic biology of erbB-2 and its participation in colorectal cancers

63%
Stawińska M., Bryś M., Krajewska W. M., University of Łódź D. o. C., pl z. b. u. l.
Acta Universitatis Lodziensis. Folia Biologica et Oecologica
|
2005
|
vol. 2
EN
ErbB-2 is one of Tour cell surface growth factor receptors involved in transmission of signals controlling normal cell growth and differentiation. A range of growth factors serve as ligands, but none is specific for the ErbB-2 receptor. Ligand binding to ErbB-1, ErbB-3 and ErbB-4 induces rapid receptor dimerization, with a marked preference for ErbB-2 as a dimer partner. When ErbB-2 is overexpressed multiple ErbB-2 heterodimers are formed and cell signalling is stronger, resulting in enhanced responsiveness to growth factors and malignant growth. This explains why ErbB-2 overexpression is an indicator of poor prognosis in colorectal cancers and may be predictive of response to treatment. ErbB-2 is a highly specific and promising target for new colon cancer treatments.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.